Side Effect Management

Anxiety, Depression May Raise Mortality Risk in Certain Cancers

Anxiety, Depression May Raise Mortality Risk in Certain Cancers

Anxiety and depression may increase the risk of death from certain cancers.

Prostate Cancer: Multidisciplinary Clinic Feasible for Mitigating Toxicities

Prostate Cancer: Multidisciplinary Clinic Feasible for Mitigating Toxicities

Participation in a multidisciplinary clinic is feasible for mitigating treatment-related toxicity among patients with newly diagnosed metastatic prostate cancer.

Study Supports Interstitial Brachytherapy-based APBI

Study Supports Interstitial Brachytherapy-based APBI

Five-year toxicity profiles and cosmetic results were similar for patients with low-risk breast cancer who underwent breast-conserving surgery.

Physical Activity Reduces Risk of Death From Cancer and Cardiovascular Disease

Physical Activity Reduces Risk of Death From Cancer and Cardiovascular Disease

In contrast with current guidelines, non-conventional physical activity patterns reduce all-cause, cardiovascular disease (CVD), and cancer mortality.

Abuse-deterrent Morphine ER Approved for Chronic Pain

Abuse-deterrent Morphine ER Approved for Chronic Pain

The FDA has approved morphine sulfate extended-release tablets (Arymo ER) for the management of pain.

Diarrhea Manageable With Pertuzumab Treatment for Breast Cancer

Diarrhea Manageable With Pertuzumab Treatment for Breast Cancer

Diarrhea is a common but manageable side effect for patients with HER2-positive breast cancer undergoing treatment with pertuzumab.

Patients Experience More Cognitive Difficulties After Chemo

Patients Experience More Cognitive Difficulties After Chemo

Compared with non-cancer controls, patients with breast cancer treated with chemotherapy have more cognitive difficulties up to six months after treatment.

Congestive Heart Failure and Anthracycline: A new Biomarker?

Congestive Heart Failure and Anthracycline: A new Biomarker?

The A allele of the SNP rs28714259 was associated with an increased risk for developing anthracycline-induced congestive heart failure.

TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia

TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia

Researchers claim that systems medicine could reduce cardiovascular toxicity caused by TKI therapy.

Lower Risk of Peripheral Neuropathy With Lenalidomide In Myeloma

Lower Risk of Peripheral Neuropathy With Lenalidomide In Myeloma

Patients with multiple myeloma have similar survival outcomes whether they are treated with thalidomide or lenalidomide.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters